Yokota, Masako <br/><br/>
Therapeutic effect of nanogel-based delivery of soluble FGFR2 with S252W mutation on craniosynostosis.  [electronic resource] 

 -  PloS one  2014 
 - e101693 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0101693  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acrocephalosyndactylia--genetics<br/>Amino Acid Substitution<br/>Animals<br/>Calcification, Physiologic--drug effects<br/>Cell Differentiation--drug effects<br/>Cell Line<br/>Codon<br/>Cranial Sutures--abnormalities<br/>Disease Models, Animal<br/>Drug Delivery Systems<br/>Female<br/>Fibroblast Growth Factor 10--genetics<br/>Fibroblast Growth Factor 2--metabolism<br/>Gene Expression<br/>Male<br/>Mice<br/>Mice, Transgenic<br/>Mutation<br/>Nanogels<br/>Osteoblasts--cytology<br/>Phenotype<br/>Polyethylene Glycols--administration & dosage<br/>Polyethyleneimine--administration & dosage<br/>Protein Binding<br/>RNA-Binding Proteins--genetics<br/>Receptor, Fibroblast Growth Factor, Type 2--administration & dosage<br/>Recombinant Proteins--administration & dosage